- Home
- FHN vs QGEN Comparison
FHN vs QGEN Comparison
Compare FHN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- QGEN
- Stock Information
- Founded
- FHN 1864
- QGEN 1986
- Country
- FHN United States
- QGEN Netherlands
- Employees
- FHN N/A
- QGEN N/A
- Industry
- FHN Major Banks
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FHN Finance
- QGEN Health Care
- Exchange
- FHN Nasdaq
- QGEN Nasdaq
- Market Cap
- FHN 10.4B
- QGEN 9.7B
- IPO Year
- FHN N/A
- QGEN 1996
- Fundamental
- Price
- FHN $20.38
- QGEN $41.28
- Analyst Decision
- FHN Buy
- QGEN Buy
- Analyst Count
- FHN 13
- QGEN 9
- Target Price
- FHN $18.31
- QGEN $51.05
- AVG Volume (30 Days)
- FHN 7.1M
- QGEN 859.9K
- Earning Date
- FHN 10-16-2024
- QGEN 11-06-2024
- Dividend Yield
- FHN 2.95%
- QGEN 3.20%
- EPS Growth
- FHN N/A
- QGEN N/A
- EPS
- FHN 1.37
- QGEN 0.41
- Revenue
- FHN $3,071,000,000.00
- QGEN $1,966,174,000.00
- Revenue This Year
- FHN N/A
- QGEN $2.68
- Revenue Next Year
- FHN $2.23
- QGEN $5.95
- P/E Ratio
- FHN $14.87
- QGEN $99.54
- Revenue Growth
- FHN 0.03
- QGEN 0.62
- 52 Week Low
- FHN $11.87
- QGEN $39.03
- 52 Week High
- FHN $20.53
- QGEN $47.44
- Technical
- Relative Strength Index (RSI)
- FHN 74.44
- QGEN 34.76
- Support Level
- FHN $19.86
- QGEN $42.71
- Resistance Level
- FHN $20.50
- QGEN $42.86
- Average True Range (ATR)
- FHN 0.44
- QGEN 0.72
- MACD
- FHN 0.19
- QGEN -0.08
- Stochastic Oscillator
- FHN 95.73
- QGEN 6.96
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The regional bank is responsible for roughly 65% of its revenue, while capital markets make a 25% contribution. The remainder is split between the firm's non-strategic (wind-down) and corporate operations. First Horizon concentrates on offering a variety of banking products mainly in its home state, where it has the second- largest deposit franchise with a 13% deposit market share.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).